C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/57 (2006.01) A61K 38/04 (2006.01) A61K 47/48 (2006.01) C07D 403/12 (2006.01) C07D 475/08 (2006.01) C07K 5/02 (2006.01) C07K 5/06 (2006.01) C12N 9/48 (2006.01) C12N 9/64 (2006.01) C12N 9/96 (2006.01) C12N 15/62 (2006.01) A61K 38/00 (2006.01)
Patent
CA 2176024
The present invention relates to improvements in targetted enzyme prodrug therapy including antibody-directed enzyme prodrug therapy (ADEPT), it particularly relates to novel enzymes and prodrugs for use in ADEPT.
La présente invention se rapporte à des améliorations apportées à la thérapie par promédicament à base d'enzyme ciblée, notamment la thérapie par promédicament à base d'enzyme dirigée contre des anticorps (ADEPT); l'invention se rapporte à des nouveaux promédicaments et enzymes destinés à être utilisés dans la thérapie ADEPT.
Blumenkopf Todd Andrew
Cory Michael
Smith Gary Keith
Riches Mckenzie & Herbert Llp
The Wellcome Foundation Limited
LandOfFree
Therapy does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Therapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapy will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1562610